Immunogenicity of subcutaneous TNF inhibitors and its clinical significance in real-life setting in patients with spondyloarthritis

被引：0
|
作者：
J. Hiltunen
P. Parmanne
T. Sokka
T. Lamberg
P. Isomäki
O. Kaipiainen-Seppänen
R. Peltomaa
T. Uutela
L. Pirilä
K. Taimen
M. J. Kauppi
T. Yli-Kerttula
R. Tuompo
H. Relas
S. Kortelainen
K. Paalanen
J. Asikainen
P. Ekman
A. Santisteban
K.-L. Vidqvist
K. Tadesse
M. Romu
J. Borodina
P. Elfving
H. Valleala
M. Leirisalo-Repo
V. Rantalaiho
H. Kautiainen
T. S. Jokiranta
K. K. Eklund
机构：
[1] Helsinki University and Helsinki University Hospital,Department of Rheumatology
[2] Jyväskylä Central Hospital,Department of Rheumatology
[3] University of Eastern Finland,Department of Rheumatology
[4] United Medix Laboratories,Department of Rheumatology
[5] Tampere University Hospital,Department of Rheumatology
[6] Kuopio University Hospital,Department of Rheumatology
[7] Central Hospital of Lapland,Department of Rheumatology
[8] Turku University Hospital,Department of Rheumatology
[9] Päijät-Häme Central Hospital,Translational Immunology Research Program
[10] University of Tampere,Department of Rheumatology
[11] Satakunta Central Hospital,undefined
[12] Medcare Foundation,undefined
[13] SYNLAB Finland,undefined
[14] Helsinki University and Orton Research Foundation,undefined
[15] Orton Hospital,undefined
[16] Mikkeli Central Hospital,undefined
来源：
Rheumatology International | 2022年 / 42卷
关键词：
Spondyloarthritis; Ankylosing spondylitis; Biological therapy; Anti-drug antibodies; Disease activity; Therapeutic drug monitoring;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1015 / 1025
页数：10
相关论文
共 50 条
  • [21] ANTICOAGULANT THERAPY AND PROGNOSIS IN PATIENTS WITH CHF AND AF IN THE SETTING OF REAL-LIFE CLINICAL PRACTICE
    Vinogradova, N. G.
    Zhirkova, M. M.
    Polyakov, D. S.
    Kraiem, N.
    Fomin, I., V
    KARDIOLOGIYA, 2017, 57 : 4 - 10
  • [22] Diagnostic performance of the MelaFind device in a real-life clinical setting
    Fink, Christine
    Jaeger, Claudia
    Jaeger, Katharina
    Haenssle, Holger A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2017, 15 (04): : 414 - 419
  • [23] INFLUENCE OF THE TAPERING STRATEGY TNF INHIBITORS ON THE IMMUNOGENICITY IN A COHORT OF SPONDYLOARTHRITIS PATIENTS IN LOW DISEASE ACTIVITY
    Monjo Henry, I.
    Plasencia, C.
    Pascual-Salcedo, D.
    Paredes, B.
    Pieren, A.
    Tornero, C.
    Moral, E.
    Bonilla, G.
    Nuno, L.
    Peiteado, D.
    Villalba, A.
    Jurado, T.
    Diego, C.
    Diez, J.
    Martin Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 270 - 270
  • [24] EMICIZUMAB THERAPY IN REAL-LIFE CLINICAL SETTING: DRAMATIC REDUCTION OF BLEEDING RATES IN CHILDREN WITH HEMOPHILIA A WITH INHIBITORS
    Zharkov, P.
    Voronin, K.
    Andreeva, T.
    Belkina, Y.
    Demichov, V.
    Kolyasina, T.
    Lebedev, V.
    Markova, I.
    Osmulskaya, N.
    Petrov, V.
    Sherstnev, D.
    Spichak, O.
    HAEMOPHILIA, 2022, 28 : 51 - 52
  • [25] Long-Term Retention Rate of Golimumab in Patients With Rheumatoid Arthritis, Psoriatic Arthritis, and Spondyloarthritis in a Real-Life Setting
    Serrano-Benavente, Belen
    Valor, Larissa
    del Rio Blasco, Tamara
    Janta, Iustina
    Gonzalez Benitez, Roberto
    Nieto-Gonzalez, Juan Carlos
    Martinez-Barrio, Julia
    Ovalles Bonilla, Juan Gabriel
    Ariza, Alfonso
    Lopez-Longo, Francisco Javier
    Alvaro-Gracia, Jose Maria
    Monteagudo, Indalecio
    Gonzalez-Fernandez, Carlos Manuel
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2022, 28 (01) : E150 - E155
  • [26] Clinical Decision Support Systems in Hospitalized Older Patients: An Exploratory Analysis in a Real-Life Clinical Setting
    Linkens, Aimee E. M. J. H.
    Kurstjens, Dennis
    Zwietering, N. Anne
    Milosevic, Vanja
    Hurkens, Kim P. G. M.
    van Nie, Noemi
    van de Loo, Bob P. A.
    van der Kuy, P. Hugo M.
    Spaetgens, Bart
    DRUGS-REAL WORLD OUTCOMES, 2023, 10 (03) : 363 - 370
  • [27] Clinical Decision Support Systems in Hospitalized Older Patients: An Exploratory Analysis in a Real-Life Clinical Setting
    Aimée E. M. J. H. Linkens
    Dennis Kurstjens
    N. Anne Zwietering
    Vanja Milosevic
    Kim P. G. M. Hurkens
    Noémi van Nie
    Bob P. A. van de Loo
    P. Hugo M. van der Kuy
    Bart Spaetgens
    Drugs - Real World Outcomes, 2023, 10 : 363 - 370
  • [28] Older and younger patients treated with immune checkpoint inhibitors have similar outcomes in real-life setting
    Corbaux, Pauline
    Maillet, Denis
    Boespflug, Amelie
    Locatelli-Sanchez, Myriam
    Perier-Muzet, Marie
    Duruisseaux, Michael
    Kiakouama-Maleka, Lize
    Dalle, Stephane
    Falandry, Claire
    Peron, Julien
    EUROPEAN JOURNAL OF CANCER, 2019, 121 : 192 - 201
  • [29] Is mild asthma truly mild? The patients' real-life setting
    Guarnieri, Gabriella
    Batani, Veronica
    Senna, Gianenrico
    Dama, Annarita
    Vianello, Andrea
    Caminati, Marco
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2022, 16 (11-12) : 1263 - 1272
  • [30] Real-Life Performance of the ASAS Health Index in Routine Care of Patients with Spondyloarthritis
    Kiltz, Uta
    Wiatr, Thomas
    Baraliakos, Xenofon
    Fedorov, Kirill
    Braun, Juergen
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
12345